tirzepatide no longer in shortage Lilly's weight-loss drug removed from FDA's list Lilly, Novo Fight Weight Loss

Obesity is a major risk factor for chronic diseases, including diabetes, cardiovascular disease, and certain cancers.[28, 29] Globally, overweight and obesity have doubled in prevalence since 1980 and are estimated to contribute to more than $700 billion in annual healthcare costs.[28, 30] As evidence has mounted for the weight loss effectiveness of GLP-1RAs, their use has grown accordingly

The MHRA explains that semaglutide acts on areas of the brain involved in appetite, helping people feel fuller for longer, reducing hunger and decreasing food cravings

As a biological medicine, Saxenda requires specific storage conditions to maintain its stability, efficacy, and safety throughout its shelf life

We recalibrated composition